이상현

이상현 appears in our data through filings on 펨토바이오메드 shares, published by DART (FSS). Between 17 February 2021 and 6 November 2025, the trades on record add up to 22 filings.

In open-market terms, that means 5 purchases on one side and 15 sales on the other. The amount is not disclosed for 20 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2025, the count stands at 5 purchases and 1 sale.

The newest entry dates from 6 November 2025: an open-market purchase, in 펨토바이오메드. Filings reach the DART (FSS) feed a median of 7 days after the trade. Until a filing is published, the market cannot know about the trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.